DDN Webinar: A CRISPR Focus on Editing

There is no denying the impact of CRISPR-Cas9 technology
as a molecular tool for understanding basic biology, but
recent advances push the gene-editing platform from analytic
resource to therapeutic solution. This webinar will present
efforts to address the challenges of genome modification as
therapy, whether by improving fidelity, introducing fail-safes, or
working ex vivo.

Speaker Information:

Gomez-Ospina

Natalia Gomez-Ospina, MD, PhD

Taube Pediatric Neurodegenerative Disease Scholar
Assistant Professor, Dept. of Pediatrics
Divisions of Medical Genetics & Stem Cell and Regenerative Medicine
Stanford University

Developing gene-based therapies for metabolic and neurodegenerative diseases.

Chatterjee (1)

Pranam Chatterjee, PhD

Carlos M. Varsavsky Research Fellow
Harvard Medical School | MIT Media Lab

Next generation CRISPR technologies for potential clinical use.

Sponsored by

Interested in sponsoring a webinar?
Click here to contact our friendly sales team.